Phase 2 Seasonal Allergic Rhinitis Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.300 enrolled30 locationsNCT07398859
Recruiting
Phase 2
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
Seasonal Allergic Rhinitis (SAR)
Alixer Nexgen Therapeutics Limited164 enrolled1 locationNCT07219849
Recruiting
Phase 2
Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Beijing Tongren Hospital120 enrolled1 locationNCT06300203
Recruiting
Phase 2
A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Guangdong Hengrui Pharmaceutical Co., Ltd100 enrolled1 locationNCT07091357
Recruiting
Phase 2Phase 3
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd160 enrolled1 locationNCT06846385